Duchenne muscular dystrophy is a genetic, progressive muscle disorder that affects males. It is caused by defects in muscle proteins and results in the death of muscle tissue. The disorder is inherited in an X-linked recessive pattern, with mothers passing the recessive gene to their sons. Symptoms include delayed development, loss of motor skills, muscle weakness, and difficulty walking or climbing stairs. Current treatments aim to improve mobility, breathing, and manage symptoms, but there is no cure. Researchers are working on gene therapy as a potential treatment by delivering dystrophin genes to muscle cells using modified viruses.